| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGYNO.2009.11.031 |
| P698 | PubMed publication ID | 20015540 |
| P50 | author | Feng Gao | Q43276868 |
| P2093 | author name string | L Stewart Massad | |
| David G Mutch | |||
| Janet S Rader | |||
| Matthew A Powell | |||
| Israel Zighelboim | |||
| Premal H Thaker | |||
| Nicholas P Taylor | |||
| Nora Kizer | |||
| Ashley S Case | |||
| P2860 | cites work | Cancer statistics, 2009 | Q29547625 |
| The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study | Q33317088 | ||
| Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 | ||
| Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study | Q34008331 | ||
| Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction | Q36682388 | ||
| Does the Surgical Apgar Score measure intraoperative performance? | Q36925834 | ||
| Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? | Q37169893 | ||
| Elderly patients with stage III or IV ovarian cancer: should they receive standard care? | Q40156485 | ||
| Correlates of length of stay in gynecologic oncology patients undergoing inpatient surgery | Q41062790 | ||
| Utility of the surgical apgar score: validation in 4119 patients | Q45292327 | ||
| The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer | Q57823598 | ||
| An Apgar Score for Surgery | Q59325273 | ||
| Response and outcomes in elderly patients with stages IIIC–IV ovarian cancer receiving platinum–taxane chemotherapy | Q60683187 | ||
| Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma | Q60685709 | ||
| Participation in Surgical Oncology Clinical Trials: Gender-, Race/Ethnicity-, and Age-based Disparities | Q61784845 | ||
| Use of the APACHE II scoring system to determine mortality of gynecologic oncology patients in the intensive care unit | Q72357209 | ||
| A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model | Q80549677 | ||
| Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm | Q83733281 | ||
| Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience | Q83936548 | ||
| Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events | Q84565902 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gynaecology | Q1221899 |
| ovarian cancer | Q172341 | ||
| obstetrics | Q5284418 | ||
| P304 | page(s) | 370-373 | |
| P577 | publication date | 2009-12-16 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | "Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer | |
| P478 | volume | 116 |
| Q90607677 | Can Surgical Apgar Score (SAS) Predict Postoperative Complications in Patients Undergoing Gynecologic Oncological Surgery? |
| Q42359711 | Can the Surgical Apgar Score predict morbidity and mortality in general orthopaedic surgery? |
| Q38965165 | Combining the ASA Physical Classification System and Continuous Intraoperative Surgical Apgar Score Measurement in Predicting Postoperative Risk |
| Q82941848 | Hospital costs associated with adverse events in gynecological oncology |
| Q88118623 | Improvement of the Surgical Apgar Score by Addition of Intraoperative Blood Transfusion Among Patients Undergoing Major Gastrointestinal Surgery |
| Q56334854 | Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study |
| Q58706465 | Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score |
| Q40351106 | Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer |
| Q40071714 | Surgical Apgar Score Predicted Postoperative Morbidity After Esophagectomy for Esophageal Cancer |
| Q86188104 | Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy |
| Q82238358 | Surgical Apgar score predicts perioperative morbidity in patients undergoing pancreaticoduodenectomy at a high-volume center |
| Q33608438 | The surgical Apgar score is strongly associated with intensive care unit admission after high-risk intraabdominal surgery |
| Q89180680 | Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review |
| Q35759607 | Use of the surgical Apgar score to guide postoperative care |
| Q88995094 | Utility of the Surgical Apgar Score in Head and Neck Squamous Cell Carcinoma |
| Q37992000 | Utility of the Surgical Apgar Score in a district general hospital |
| Q38931964 | Validation of the Surgical Apgar Score After Laparotomy at a Tertiary Referral Hospital in Rwanda |
Search more.